Back
Kiniksa Pharmaceuticals International PLC Vs. Vanda Pharmaceuticals Industry Stock Comparison
Sell
41
KNSA
Kiniksa Pharmaceuticals International PLC
Last Price:
$20.60
Seasonality Move:
-9.83%
Sell
33
VNDA
Vanda Pharmaceuticals
Last Price:
$4.78
Seasonality Move:
-2.27%
Sell
41
Kiniksa Pharmaceuticals International PLC (KNSA)
is a Sell
Is Kiniksa Pharmaceuticals International PLC a Buy, Sell or Hold?
-
The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $20.59. The Score for KNSA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
KNSA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Vanda Pharmaceuticals (VNDA)
is a Sell
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
-
The current Vanda Pharmaceuticals [VNDA] share price is $4.78. The Score for VNDA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
VNDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KNSA Stock Price Chart
What is Kiniksa Pharmaceuticals International PLC's stock price today?
-
The Kiniksa Pharmaceuticals International PLC share price today is $20.59Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSA is experiencing buying pressure, which is a positive indicator for future bullish movement.
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $4.78The current trend is relatively stagnant and VNDA is experiencing buying pressure, which is a positive indicator for future bullish movement.
KNSA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.62 | Sell |
Relative Strength Index (14 RSI): | 40.95 | Sell |
Chaikin Money Flow: | 350750 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.52 - 21.74) | Sell |
Bollinger Bands (100): | (21.93 - 26.25) | Sell |
VNDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 49.02 | Sell |
Chaikin Money Flow: | 501740 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.67 - 5.03) | Sell |
Bollinger Bands (100): | (4.64 - 5.24) | Sell |
KNSA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.45 | Buy |
20-day SMA: | 21.12 | Sell |
50-day SMA: | 22.85 | Sell |
200-day SMA: | 21.88 | Sell |
8-day EMA: | 20.56 | Buy |
20-day EMA: | 21.07 | Sell |
50-day EMA: | 22.21 | Sell |
200-day EMA: | 21.86 | Sell |
VNDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.65 | Buy |
20-day SMA: | 4.83 | Sell |
50-day SMA: | 4.84 | Sell |
200-day SMA: | 5.02 | Sell |
8-day EMA: | 4.69 | Buy |
20-day EMA: | 4.77 | Buy |
50-day EMA: | 4.85 | Sell |
200-day EMA: | 5 | Sell |
Kiniksa Pharmaceuticals International PLC Earnings Growth & KNSA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.89 per share.
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kiniksa Pharmaceuticals International PLC Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vanda Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |